Single-cell profiling of tumor-infiltrating TCF1/TCF7+ T cells reveals a T lymphocyte subset associated with tertiary lymphoid structures/organs and a superior prognosis in oral cancer

Yu Peng,Liping Xiao,Haixu Rong,Zhanpeng Ou,Tingting Cai,Niu Liu,Bowen Li,Lizao Zhang,Fan Wu,Tianjun Lan,Xinyu Lin,Qunxing Li,Siqi Ren,Song Fan,Jinsong Li
DOI: https://doi.org/10.1016/j.oraloncology.2021.105348
IF: 5.972
2021-08-01
Oral Oncology
Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Objectives</h3><p>Despite substantial advances in treatment, clinical outcomes for oral squamous cell carcinoma (OSCC) remain unsatisfactory. Tumor-infiltrating lymphocytes (TILs) are an important prognostic factor for patients and are heterogeneous. Some studies have suggested that TCF1/TCF7<sup>+</sup> T cells and tertiary lymphatic structure/organ (TLS) play an important role in tumor immunity. However, how they affect tumor immunity and whether they are related to prognosis in OSCC have not been reported in detail.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Materials and methods</h3><p>We isolated OSCC cells and performed single-cell RNA sequencing (scRNA-seq). We used immunohistochemistry (IHC) to analyze the relationship between TLSs and prognosis. Multiplex immunohistochemistry (MIHC), flow cytometry (FCM) and spatial analysis were performed to verify the characteristics of TCF1/TCF7<sup>+</sup> T cells. The prognostic significance and upstream regulatory network of the TCF1/TCF7<sup>+</sup> T cell subpopulation were determined by multivariate analysis and Scenic software.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Results</h3><p>We found a strong association between TCF1/TCF7<sup>+</sup> T cell subsets, TLSs and prognosis. The results suggested that TCF1/TCF7<sup>+</sup> T cells express high levels of TLS-related genes and low levels of immune checkpoint molecules. Finally, we found that TCF1/TCF7<sup>+</sup> T cells were significantly associated with favorable outcomes. We also describe the upstream drivers that these cells rely on.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusions</h3><p>TCF1/TCF7<sup>+</sup> T cells could be used as a new therapeutic target to regulate the immune response of OSCC and are expected to be a new prognostic marker.</p>
dentistry, oral surgery & medicine,oncology
What problem does this paper attempt to address?